LifeMD, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $14.4M | $-21.4M | $-20.6M | $-45.5M | $-60.9M | $-58.6M | $-3.1M | $-1.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $865.5K | $465.8K | $204.0K | $161.9K | $13.6K | — | — | — |
| Amortization | $94.0K | $26.7K | $971.5K | $926.5K | $342.3K | $335.6K | $335.6K | $195.8K |
| Stock-Based Compensation | $10.5M | $12.2M | $12.5M | $13.7M | $12.1M | $18.7M | $733.2K | $273.6K |
| Net Cash from Operating Activities | $8.3M | $17.5M | $8.8M | $-22.9M | $-33.1M | $-12.1M | $251.4K | $-905.5K |
| Investing Activities | ||||||||
| Capital Expenditures | $1.9M | $1.5M | $203.8K | $366.6K | $247.4K | — | — | — |
| Business Acquisitions | — | — | — | $1.0M | — | — | — | $148.6K |
| Net Cash from Investing Activities | $6.9M | $-11.5M | $-8.7M | $-13.9M | $-3.4M | $-798.1K | $-100.0K | $141.4K |
| Financing Activities | ||||||||
| Dividends Paid | $3.1M | $3.1M | $3.1M | $3.1M | $871.5K | — | — | — |
| Stock Repurchases | $270.0K | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-13.4M | $-4.1M | $29.1M | $-528.2K | $68.6M | $21.0M | $775.1K | $802.8K |
| Net Change in Cash | $1.8M | $1.9M | $29.2M | $-37.4M | $32.1M | $8.1M | $926.5K | $38.7K |
| Free Cash Flow | $6.4M | $16.0M | $8.6M | $-23.3M | $-33.3M | — | — | — |